MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 158 filers reported holding MANNKIND CORP in Q3 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $24,000 | -42.9% | 38,267 | -43.4% | 0.00% | 0.0% |
| Q3 2016 | $42,000 | -51.2% | 67,661 | -8.1% | 0.00% | -66.7% |
| Q2 2016 | $86,000 | -37.2% | 73,590 | -13.1% | 0.00% | -25.0% |
| Q1 2016 | $137,000 | +10.5% | 84,699 | -1.3% | 0.00% | 0.0% |
| Q4 2015 | $124,000 | -61.0% | 85,819 | -13.6% | 0.00% | -60.0% |
| Q3 2015 | $318,000 | -43.8% | 99,346 | -0.3% | 0.01% | -37.5% |
| Q2 2015 | $566,000 | +15.5% | 99,625 | +5.6% | 0.02% | +23.1% |
| Q1 2015 | $490,000 | -1.2% | 94,356 | -0.8% | 0.01% | -7.1% |
| Q4 2014 | $496,000 | -10.5% | 95,093 | +1.6% | 0.01% | -12.5% |
| Q3 2014 | $554,000 | -39.0% | 93,569 | +13.0% | 0.02% | -40.7% |
| Q2 2014 | $908,000 | +194.8% | 82,817 | +8.2% | 0.03% | +200.0% |
| Q1 2014 | $308,000 | -20.2% | 76,537 | +3.1% | 0.01% | -25.0% |
| Q4 2013 | $386,000 | -15.2% | 74,207 | -7.0% | 0.01% | -25.0% |
| Q3 2013 | $455,000 | +20.4% | 79,757 | +37.3% | 0.02% | +6.7% |
| Q2 2013 | $378,000 | – | 58,094 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AYM CAPITAL, LLC | 1,305,000 | $7,713,000 | 5.61% |
| Greywolf Capital Management LP | 6,206,570 | $36,681,000 | 4.08% |
| AYM CAPITAL, LLC | 692,300 | $4,092,000 | 2.98% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,412,600 | $8,348,000 | 2.26% |
| B. Riley Wealth Advisors, Inc. | 1,238,880 | $7,322,000 | 1.11% |
| ZEKE LP /PA | 50,000 | $295,000 | 1.06% |
| Old West Investment Management, LLC | 266,566 | $1,575,000 | 0.99% |
| Cohen Capital Management, Inc. | 500,000 | $2,955,000 | 0.79% |
| Tourbillon Capital Partners, L.P. | 3,250,000 | $19,208,000 | 0.70% |
| Adamant Biomedical Investments AG | 300,000 | $1,773,000 | 0.44% |